(+/-)-[1,5]naphthyridine-2-carboxylic acid (4-oxo-2-pyrimidin-4-yl-5,6,8,9-tetrahydro-4H-7-oxa-1,4a-diaza-benzocyclohepten-9-yl)-amide | 1175532-18-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: (+/-)-[1,5]naphthyridine-2-carboxylic acid (4-oxo-2-pyrimidin-4-yl-5,6,8,9-tetrahydro-4H-7-oxa-1,4a-diaza-benzocyclohepten-9-yl)-amide
• 英文别名: N-(4-oxo-2-pyrimidin-4-yl-6,7,9,10-tetrahydropyrimido[1,2-d][1,4]oxazepin-10-yl)-1,5-naphthyridine-2-carboxamide
• CAS: 1175532-18-9
• 化学式: C₂₁H₁₇N₇O₃
• 分子量: 415.411
• InChiKey: WDISAUIVXMBTPB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  31
• 可旋转键数：
  3
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  123
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• SUBSTITUTED HETEROARYLAMIDE OXAZEPINOPYRIMIDONE DERIVATIVES
  申请人：Sanofi-Aventis

  公开号：EP2247598A1

  公开（公告）日：2010-11-10
• [EN] SUBSTITUTED HETEROARYLAMIDE OXAZEPINOPYRIMIDONE DERIVATIVES<br/>[FR] DÉRIVÉS D'HÉTÉROARYLAMIDE OXAZÉPINOPYRIMIDONE SUBSTITUÉS
  申请人：SANOFI AVENTIS

  公开号：WO2009095787A1

  公开（公告）日：2009-08-06

  A pyrimidone derivative represented by Formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof: Formula (I) wherein: Y represents two hydrogen atoms, a sulphur atom, an oxygen atom or a C1-2 alkyl group and a hydrogen atom; Z represents a bond, an oxygen atom, a nitrogen atom substituted by a hydrogen atom or a C1-3 alkyl group, a sulphur atom, a methylene group optionally substituted by one or two groups chosen from a Ci-6 alkyl group, a hydroxyl group, a C1-6 alkoxy group, a C1-2 perhalogenated alkyl group or an amino group; R1 represents a 2, 3 or 4-pyridine ring or a 2, 4 or 5-pyrimidine ring, the ring being optionally substituted by a C1-6 alkyl group, a C1-6 alkoxy group or a halogen atom; R2 represents a hydrogen atom, a C1-6 alkyl group or a halogen atom; R3 represents a 4-15 membered heterocyclic group, this group being optionally substituted; R4 represents a hydrogen atom or a C1-6 alkyl group; and n represents 0 to 3 and their therapeutic use.